Rodriguez, S.M.B.; Tataranu, L.G.; Kamel, A.; Turliuc, S.; Rizea, R.E.; Dricu, A.
Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions. Int. J. Mol. Sci. 2024, 25, 10765.
https://doi.org/10.3390/ijms251910765
AMA Style
Rodriguez SMB, Tataranu LG, Kamel A, Turliuc S, Rizea RE, Dricu A.
Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions. International Journal of Molecular Sciences. 2024; 25(19):10765.
https://doi.org/10.3390/ijms251910765
Chicago/Turabian Style
Rodriguez, Silvia Mara Baez, Ligia Gabriela Tataranu, Amira Kamel, Serban Turliuc, Radu Eugen Rizea, and Anica Dricu.
2024. "Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions" International Journal of Molecular Sciences 25, no. 19: 10765.
https://doi.org/10.3390/ijms251910765
APA Style
Rodriguez, S. M. B., Tataranu, L. G., Kamel, A., Turliuc, S., Rizea, R. E., & Dricu, A.
(2024). Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions. International Journal of Molecular Sciences, 25(19), 10765.
https://doi.org/10.3390/ijms251910765